Jazz Pharmaceuticals plc buy Truist Financial Co.
Start price
20.03.24
/
50%
€115.00
Target price
20.03.25
€184.14
Performance (%)
-13.34%
Price
04.10.24
€99.66
Summary
This prediction is currently active. The prediction for Jazz Pharmaceuticals plc disappoints with a performance of -13.34%. This prediction currently runs until 20.03.25. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Jazz Pharmaceuticals plc | 1.178% | 1.178% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $200.00 price target on the stock.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Truist_Financial_Co_ for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€112.25
04.12.23
04.12.23
€184.92
04.12.24
04.12.24
-12.66%
04.10.24
04.10.24